EE+ POEM Archive
Warfarin provides greater net benefit than rivaroxaban for patients with atrial fibrillation and rheumatic heart disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Warfarin Provides Greater Net Benefit Than Rivaroxaban for Patients With Atrial Fibrillation and Rheumatic Heart Disease." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315715/all/Warfarin_provides_greater_net_benefit_than_rivaroxaban_for_patients_with_atrial_fibrillation_and_rheumatic_heart_disease.
Warfarin provides greater net benefit than rivaroxaban for patients with atrial fibrillation and rheumatic heart disease. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315715/all/Warfarin_provides_greater_net_benefit_than_rivaroxaban_for_patients_with_atrial_fibrillation_and_rheumatic_heart_disease. Accessed April 25, 2024.
Warfarin provides greater net benefit than rivaroxaban for patients with atrial fibrillation and rheumatic heart disease. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315715/all/Warfarin_provides_greater_net_benefit_than_rivaroxaban_for_patients_with_atrial_fibrillation_and_rheumatic_heart_disease
Warfarin Provides Greater Net Benefit Than Rivaroxaban for Patients With Atrial Fibrillation and Rheumatic Heart Disease [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 April 25]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315715/all/Warfarin_provides_greater_net_benefit_than_rivaroxaban_for_patients_with_atrial_fibrillation_and_rheumatic_heart_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Warfarin provides greater net benefit than rivaroxaban for patients with atrial fibrillation and rheumatic heart disease
ID - 1315715
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315715/all/Warfarin_provides_greater_net_benefit_than_rivaroxaban_for_patients_with_atrial_fibrillation_and_rheumatic_heart_disease
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
